Optimization Manufacture of Virus- and Tumor-Specific T Cells
Although ex vivo expanded T cells are currently widely used in pre-clinical and clinical trials, the complexity of manufacture remains a major impediment for broader application. In this review we discuss current protocols for the ex vivo expansion of virus- and tumor-specific T cells and describe o...
Saved in:
Main Authors: | Natalia Lapteva, Juan F. Vera |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.4061/2011/434392 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgical treatment of patients with renal cell cancer complicated by specific (tumor) and non-specific thrombosis of the inferior Vena cava
by: N. V. Vorobev, et al.
Published: (2020-09-01) -
The Influence of the Laser Power on the Manufacturing Quality Specific to Automotive Parts
by: Dumitrascu Dorin-Ion, et al.
Published: (2025-01-01) -
Arginase-1-specific T cells target and modulate tumor-associated macrophages
by: Mads Hald Andersen, et al.
Published: (2025-01-01) -
Evaluation of Epstein-Barr Virus Latent Membrane Protein 2 Specific T-Cell Receptors Driven by T-Cell Specific Promoters Using Lentiviral Vector
by: Dongchang Yang, et al.
Published: (2011-01-01) -
Delay equations modeling the effects of phase-specific drugs and immunotherapy on proliferating tumor cells
by: Maria Vittoria Barbarossa, et al.
Published: (2012-02-01)